3rd Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$360,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

H.R. 501, the Block, Report, and Suspend Suspicious Shipments Act; S. 2666, the E-Prescribing Parity for Controlled Substances Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Drug Enforcement Administration (DEA)

Bills named: S. 2666 (118th), H.R. 501 (118th)

Medicare/Medicaid MMM

H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Small Business Administration (SBA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5400 (118th), H.R. 5393 (118th), H.R. 2816 (118th), S. 2129 (118th), H.R. 1613 (118th), S. 2052 (118th), H.R. 2880 (118th), S. 2477 (118th), S. 2405 (118th), H.R. 5378 (118th), S. 2436 (118th), H.R. 5385 (118th), S. 1491 (118th), S. 1967 (118th), H.R. 1770 (118th), H.R. 3281 (118th), H.R. 3561 (118th), H.R. 3282 (118th), S. 1038 (118th), S. 2973 (118th)

Pharmacy PHA

H.R. 167, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2023; H.R. 382, the Pandemic is Over Act; H.R. 2679, the Pharmacy Benefits Manager Accountability Act; H.R. 3008, the Drug Shortage Prevention Act; S. 1339, the Pharmacy Benefits Manager Reform Act; S. 1542, the Delinking Revenue from Unfair Gouging Act; H.R. 5142, the Vaccine Injury Compensation Modernization Act of 2023; H.R. 5143, the Vaccine Access Improvement Act of 2023; S. 2305, the Biosimilar Red Tape Elimination Act; H.R. 1173, the Patients Right to Know Their Medication Act of 2023; Proposed rule for Medication Guides: Patient Medication Information (Docket No. FDA-2019-N-5959); Implementation of Public Law 113-54, the Drug Quality and Security Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA)

Bills named: S. 2305 (118th), H.R. 5142 (118th), H.R. 382 (118th), H.R. 2679 (118th), H.R. 5143 (118th), H.R. 167 (118th), S. 1339 (118th), S. 1542 (118th), H.R. 3008 (118th), H.R. 1173 (118th)

Taxation/Internal Revenue Code TAX

S. 1108, the Death Tax Repeal Act; H.R. 4794, the Dietary Supplement Access Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: Internal Revenue Service (IRS); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4794 (118th), S. 1108 (118th)

Labor Issues/Antitrust/Workplace LBR

S. 127, the PBM Transparency Act; S. 113, the Prescription Pricing for the People Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —
MATTHEW SEILER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: S. 113 (118th), S. 127 (118th)

Defense DEF

TRICARE pharmacy network changes; H.R. 2670, the Military Construction Authorization Act for Fiscal Year 2024

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Bills named: H.R. 2670 (118th)

Budget/Appropriations BUD

FY24 appropriations language request to fund FTC enforcement of the Robinson-Patman Act; FY24 appropriations report language to address pharmacy compounding; FY24 appropriations report language to address TRICARE pharmacy network

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Small Business SMB

H.R.4035 / S. 2623, the Protecting Small Business Information Act of 2023

LobbyistCovered position, as disclosed
ANNE CASSITY —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KAITLIN KRELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2623 (118th), H.R. 4035 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.